Boothbay Fund Management, LLC Nurix Therapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

  • $3.27 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$18.93 - $25.69 $908,526 - $1.23 Million
-47,994 Reduced 40.98%
69,134 $1.55 Million
Q2 2024

Aug 14, 2024
BUY
$12.02 - $21.3 $449,043 - $795,725
37,358 Added 46.83%
117,128 $2.44 Million
Q1 2024

May 15, 2024
BUY
$7.77 - $15.66 $619,812 - $1.25 Million
79,770 New
79,770 $1.17 Million

Others Institutions Holding NRIX

# of Institutions
184
Shares Held
67M
Call Options Held
318K
Put Options Held
42.4K
View Full List

About Nurix Therapeutics, Inc.

NRIX Quotes by TradingView
  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $573M
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email